| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8725403 | Clinics and Research in Hepatology and Gastroenterology | 2018 | 10 Pages |
Abstract
In CHB patients, LS assessed by ARFI was gradually reduced during antiviral therapy. Longitudinal monitoring of LS may be a promising noninvasive assessment of fibrosis regression during long-term antiviral therapy in CHB. Further large sample studies are needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Sheng-Di Wu, Hong Ding, Li-Li Liu, Yuan Zhuang, Yun Liu, Li-Sha Cheng, Si-Qi Wang, Yu-Jen Tseng, Ji-Yao Wang, Wei Jiang,